Marvel Biosciences (TSXV:MRVL) Days Payable : 3,141.90 (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences Days Payable?

Marvel Biosciences's average Accounts Payable for the three months ended in Jan. 2024 was C$1.52 Mil. Marvel Biosciences's Cost of Goods Sold for the three months ended in Jan. 2024 was C$0.04 Mil. Hence, Marvel Biosciences's Days Payable for the three months ended in Jan. 2024 was 3,141.90.

The historical rank and industry rank for Marvel Biosciences's Days Payable or its related term are showing as below:

TSXV:MRVL' s Days Payable Range Over the Past 10 Years
Min: 28.58 Med: 82.23 Max: 306.29
Current: 306.29

During the past 4 years, Marvel Biosciences's highest Days Payable was 306.29. The lowest was 28.58. And the median was 82.23.

TSXV:MRVL's Days Payable is ranked better than
68.24% of 721 companies
in the Biotechnology industry
Industry Median: 148.28 vs TSXV:MRVL: 306.29

Marvel Biosciences's Days Payable declined from Jan. 2023 (3,178.54) to Jan. 2024 (3,141.90). It may suggest that Marvel Biosciences accelerated paying its suppliers.

Marvel Biosciences Days Payable Historical Data

The historical data trend for Marvel Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Days Payable Chart

Marvel Biosciences Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Days Payable

129.47

28.58

34.99

302.11

Marvel Biosciences Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Days Payable	Get a 7-Day Free Trial										3,178.54	89.63	110.12	588.39	3,141.90

Competitive Comparison of Marvel Biosciences's Days Payable

For the Biotechnology subindustry, Marvel Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marvel Biosciences's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's Days Payable falls into.

Marvel Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Marvel Biosciences's Days Payable for the fiscal year that ended in Jul. 2023 is calculated as

	Days Payable (A: Jul. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jul. 2022 )	+	Accounts Payable (A: Jul. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jul. 2023 )	*	Days in Period
=	( (0.262	+	1.208)	/	2 )	/	0.888	*	365
=	0.735					/	0.888	*	365
=	302.11

Marvel Biosciences's Days Payable for the quarter that ended in Jan. 2024 is calculated as:

	Days Payable (Q: Jan. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Oct. 2023 )	+	Accounts Payable (Q: Jan. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jan. 2024 )	*	Days in Period
=	( (1.526	+	1.504)	/	2 )	/	0.044	*	365 / 4
=	1.515					/	0.044	*	365 / 4
=	3,141.90

Marvel Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences (TSXV:MRVL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MBCOF:USA

Address

505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2

Website

https://www.marvelbiotechnology.com

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Executives

Joseph Roderick Matheson

Director, Senior Officer